Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.

Autor: Onega T; University of Utah and Huntsman Cancer Institute, Salt Lake City, UT, USA. tracy.onega@hci.utah.edu., Garcia M; University of Washington, Seattle, WA, USA., Beaber EF; University of Washington, Seattle, WA, USA., Haas JS; Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA., Breslau ES; National Cancer Institute, Bethesda, MD, USA., Tosteson ANA; Dartmouth College and Dartmouth Cancer Center, Lebanon, NH, USA., Halm E; Rutgers University, New Brunswick, NJ, USA., Chao CR; Kaiser Permanente Southern California, Pasadena, CA, USA., Barlow WE; SWOG Statistics and Data Management Center, Seattle, WA, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Jun; Vol. 39 (8), pp. 1324-1331. Date of Electronic Publication: 2023 Dec 14.

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings.

Autor: Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Beaber EF; Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington, USA., Kamineni A; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Mao C; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA., Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Tiro JA; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, USA., Skinner C; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, USA., Garcia M; Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington, USA., Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Winer RL; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA., Raine-Bennett T; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Medicines360, San Francisco, California, USA., Feldman S; Division of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wheeler CM; Center for HPV Prevention, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA.

Publikováno v: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3705-3717. Date of Electronic Publication: 2022 Sep 15.

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.

Autor: Beaber EF; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Kamineni A; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Burnett-Hartman AN; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado., Hixon B; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado., Kobrin SC; Division of Cancer Control and Population Sciences, NCI, Bethesda, Maryland., Li CI; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Oliver M; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Rendle KA; Departments of Family Medicine and Community Health and of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Skinner CS; Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.; Simmons Comprehensive Cancer Center, Dallas, Texas., Todd K; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Zheng Y; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Ziebell RA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Breslau ES; Division of Cancer Control and Population Sciences, NCI, Bethesda, Maryland., Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California., Greenlee RT; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin., Haas JS; Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts., Halm EA; Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey., Honda S; Hawaii Permanente Medical Group, Kaiser Permanente Center for Integrated Health Care Research, Honolulu, Hawaii., Neslund-Dudas C; Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan., Ritzwoller DP; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado., Schottinger JE; Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California., Tiro JA; Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.; Simmons Comprehensive Cancer Center, Dallas, Texas., Vachani A; Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Doria-Rose VP; Division of Cancer Control and Population Sciences, NCI, Bethesda, Maryland.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2022 Aug 02; Vol. 31 (8), pp. 1521-1531.

Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Autor: Barlow WE; Cancer Research and Biostatistics, Seattle, WA., Beaber EF; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Geller BM; Departments of Family Medicine, and the University of Vermont Cancer Center, University of Vermont, Burlington, VT., Kamineni A; Kaiser Permanente Washington Health Research Institute, Seattle, WA., Zheng Y; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Haas JS; Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Dana Farber, Harvard Cancer Institute, Harvard School of Public Health, Boston, MA., Chao CR; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA., Rutter CM; RAND Corporation, Santa Monica, CA., Zauber AG; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Sprague BL; Departments of Surgery and Radiology, University of Vermont, Burlington, VT., Halm EA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, Dallas, TX., Weaver DL; Department of Pathology and the UVM Cancer Center, University of Vermont, Burlington, VT., Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, WA., Doria-Rose VP; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA.; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD., Kobrin S; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD., Onega T; Departments of Biomedical Data Science, Epidemiology, and the Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH., Quinn VP, Schapira MM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, and CMC VA Medical Center, Philadelphia, PA., Tosteson ANA; The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH., Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Skinner CS; Simmons Comprehensive Cancer Center, Dallas, TX.; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX., Schnall MD; Department of Radiology, University of Pennsylvania, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Armstrong K; General Medicine Division, MA General Hospital, Harvard Medical School, Boston, MA., Wheeler CM; Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Science Center, Albuquerque, NM.; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM., Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Balasubramanian BA; Simmons Comprehensive Cancer Center, Dallas, TX.; UTHealth School of Public Health, Dallas, TX., Doubeni CA; Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., McLerran D; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Tiro JA; Simmons Comprehensive Cancer Center, Dallas, TX.; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Mar 01; Vol. 112 (3), pp. 238-246.

Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.

Autor: Beaber EF; 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Sprague BL; 2Department of Surgery, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont.; 3Department of Radiology, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont., Tosteson ANA; 4The Dartmouth Institute for Health Policy and Clinical Practice, Department of Medicine, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Haas JS; 5Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts., Onega T; 6Department of Biomedical Data Science, The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.; 7Department of Epidemiology, The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Schapira MM; 8Division of General Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., McCarthy AM; 9Department of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts., Li CI; 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Herschorn SD; 10Department of Radiology, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont., Lehman CD; 11Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts., Wernli KJ; 12Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Barlow WE; 13Cancer Research and Biostatistics, Seattle, Washington.

Publikováno v: Journal of women's health (2002) [J Womens Health (Larchmt)] 2019 Aug; Vol. 28 (8), pp. 1051-1059. Date of Electronic Publication: 2018 Nov 27.